{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:19:36Z","timestamp":1787897976727,"version":"build-2784847793"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10120-026-01774-3","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:52:22Z","timestamp":1782283942000},"page":"1015-1023","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological characteristics of gastric papillary adenocarcinoma compared with tubular adenocarcinoma"],"prefix":"10.1007","volume":"29","author":[{"given":"Taku","family":"Hattori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2967-8267","authenticated-orcid":false,"given":"Masanori","family":"Terashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadakazu","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Koseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Fujiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Tanizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"1774_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"1774_CR2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S1470-2045(08)70072-X","volume":"9","author":"WK Leung","year":"2008","unstructured":"Leung WK, Wu M\u2013S, Kakugawa Y, Kim JJ, Yeoh K\u2013G, Goh KL, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9:279\u201387.","journal-title":"Lancet Oncol"},{"key":"1774_CR3","unstructured":"WHO classification of tumours editorial board. WHO Classification of Tumours. 5th edition. Lyon: IARC. 2019:45\u201358."},{"key":"1774_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31\u201349.","journal-title":"Acta Pathol Microbiol Scand"},{"key":"1774_CR5","unstructured":"Association Japanese Gastric Cancer. japanese classification of gastric carcinoma. 15. Tokyo: Kanehara Shuppan. 2017."},{"key":"1774_CR6","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1002\/1097-0142(20001001)89:7<1418::AID-CNCR2>3.0.CO;2-A","volume":"89","author":"Y Adachi","year":"2000","unstructured":"Adachi Y, Yasuda K, Inomata M, Shiraishi S, Kitano S. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer. 2000;89:1418\u201324.","journal-title":"Cancer"},{"key":"1774_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MCG.0000000000000914","volume":"53","author":"XY Wang","year":"2019","unstructured":"Wang XY, Yan J, Wu J, Zhang YF, Zhang GX. A comparison by meta-analysis of papillary early gastric carcinoma to its tubular counterpart for the risk of lymph node metastasis and submucosal invasion. J Clin Gastroenterol. 2019;53:19\u201324.","journal-title":"J Clin Gastroenterol"},{"key":"1774_CR8","doi-asserted-by":"publisher","first-page":"19686","DOI":"10.1038\/s41598-025-03972-y","volume":"4","author":"J Chen","year":"2025","unstructured":"Chen J, Cui X, Zhou C, Jin M. Clinicopathological features and mucin expression of early papillary gastric adenocarcinoma. Sci Rep. 2025;4:19686.","journal-title":"Sci Rep"},{"key":"1774_CR9","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00595-021-02289-3","volume":"51","author":"X Wang","year":"2021","unstructured":"Wang X, Deng J, Liang H. Well differentiated carcinoma with a poor prognosis: a retrospective analysis of papillary gastric adenocarcinoma. Surg Today. 2021;51:1387\u201396.","journal-title":"Surg Today"},{"key":"1774_CR10","doi-asserted-by":"publisher","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2025, 7th ed. Gastric Cancer. 2026. https:\/\/doi.org\/10.1007\/s10120-025-01698-4.","DOI":"10.1007\/s10120-025-01698-4"},{"key":"1774_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187\u201396.","journal-title":"Ann Surg"},{"key":"1774_CR12","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"AB Edge","year":"2010","unstructured":"Edge AB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471\u20134.","journal-title":"Ann Surg Oncol"},{"key":"1774_CR13","first-page":"251","volume":"3","author":"B Hu","year":"2012","unstructured":"Hu B, El Hajj N, Sittler S, Lammert N, Barnes R, Meloni-Ehrig A. Gastric cancer: classification, histology and application of molecular pathology. J Gastrointest Oncol. 2012;3:251\u201361.","journal-title":"J Gastrointest Oncol"},{"key":"1774_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/PL00011687","volume":"4","author":"K Yasuda","year":"2000","unstructured":"Yasuda K, Adachi Y, Shiraishi N, Maeno S, Kitano S. Papillary adenocarcinoma of the stomach. Gastric Cancer. 2000;4:33\u20138.","journal-title":"Gastric Cancer"},{"key":"1774_CR15","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/1097-0142(20000815)89:4<724::AID-CNCR2>3.0.CO;2-4","volume":"89","author":"K Koseki","year":"2000","unstructured":"Koseki K, Takizawa T, Koike M, Ito M, Nihei Z, Sugihara K. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer. 2000;89:724\u201332.","journal-title":"Cancer"},{"key":"1774_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4235\/agmr.21.0144","volume":"26","author":"Y Choi","year":"2022","unstructured":"Choi Y, Kim N, Kim KW, Jo HH, Park J, Yoon H, et al. Gastric cancer in older patients: a retrospective study and literature review. Ann Geriatr Med Res. 2022;26:33\u201341.","journal-title":"Ann Geriatr Med Res"},{"key":"1774_CR17","doi-asserted-by":"publisher","DOI":"10.7150\/jca.17326","author":"H Yu","year":"2017","unstructured":"Yu H, Fang C, Chen L, Shi J, Fan X, Zou X, et al. Worse prognosis in papillary, compared to tubular, early gastric carcinoma. J Cancer. 2017. https:\/\/doi.org\/10.7150\/jca.17326.","journal-title":"J Cancer"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-026-01774-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-026-01774-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-026-01774-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:53:17Z","timestamp":1787896397000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10120-026-01774-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1774"],"URL":"https:\/\/doi.org\/10.1007\/s10120-026-01774-3","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"24 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MT has received honorarium from Taiho Pharmaceutical Co. Ltd., Chugai Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Bristol Myers Squib Japan K.K., Yakult Honsha Co., Ltd, Takeda Pharmaceutical Co., Ltd, Eli Lilly Japan K.K., Pfizer Japan Inc., Daiichi Sankyo Ltd., Johnson and Johnson K.K., Medtronic Japan Co., Ltd., Intuitive Japan Inc., and Olympus Co., Ltd. EB has received honorarium from Daiichi Sankyo Ltd.; Johnson and Johnson K.K.; Medtronic Japan Co., Ltd.; Intuitive Japan Inc.; Kaken Pharmaceutical; EIZO Corporation, TERUMO CORPORATION, and EIZAI Co. The other authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were conducted in accordance with the ethical standards of the corresponding committees on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. All aspects of this study were approved by the institutional review board at Shizuoka Cancer Center (J2023-23-2023-1).","order":2,"name":"Ethics","label":"Human and animal rights and informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The need for written informed consent from the patients was waived because of the retrospective nature of the study. The opt-out method for obtaining patient consent was instead used.","order":3,"name":"Ethics","label":"Patient consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}